ProFuse

Dr. Eigler-Hirsh has expertise in muscle development and regenerative biology and as well as processes of muscle stem cell differentiation, fusion, and maturation. Tamar’s postdoctoral research was focused on processes involved in the regulation of muscle progenitor cell differentiation and fusion. She characterized the molecular signaling pathway which is the basis of the ProFuse technology. Dr. Eigler-Hirsh received her BA from Brandeis University (Waltham, Massachusetts), then a PhD in biomedical sciences and translational medicine under the mentorship of Shlomo Melmed at Cedars-Sinai Medical Center, Los Angeles, California. Her doctoral work in molecular endocrinology focused on somatostatin receptor regulation of growth hormone synthesis in pituitary tumors. She then completed postdoctoral training under the mentorship of Prof. Tzahor at the Weizmann Institute of Science where she was the recipient of the Dean of Faculty postdoctoral fellowship.

A seasoned entrepreneur with over 20 years of extensive experience in management, fund raising, marketing, business development, and sales, Guy has expertise in the fields of technology, automotive, energy storage, internet of things (IoT), imaging, smartphone developments, and wireless power. Guy has a proven record of growing startups from inception to exit as well as management positions in global companies. A great supporter of sustainability, a former chef, and vegan for over 10 years, Guy brings a passion for promoting new technologies and ideas to the food industry. Guy earned his BSc in international business management, summa cum laude, from University of Surrey, UK, and is a graduate of modules in the executive program of Northwestern University - Kellogg School of Management.

Tzahor serves as the head of the molecular cell biology department at the Weizmann Institute of Science; his laboratory focuses on the development of novel therapeutic approaches by understanding the signaling mechanisms and cellular circuits that regulate muscle biology. Dr. Tzahor has published around 70 papers and numerous patents. He is the recipient of several prestigious grants and awards, including two European Research Council (ERC) grants, Foundation LeDucq, Horizon 2020 Regenerative Medicine, and the Levinson Prize in Biology. In recent years Prof. Tzahor has been involved in commercial and business development efforts for launching cardiac regeneration-targeted novel therapies.

Dr. Avinoam is an expert in processes of cell-to-cell fusion and membrane remodeling, as well as multi-modal imaging techniques. A primary research focus of Dr. Avinoam’s laboratory is understanding the molecular mechanisms which regulate muscle cell fusion. He earned a BSc in molecular biochemistry from the Technion – Israeli Institute of Technology and his PhD in biology from the Technion in 2012 studying the mechanism by which membrane proteins enable cell-to-cell fusion. A postdoctoral fellowship followed at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany where he worked to develop the means to visualize dynamic changes in membrane architecture. He joined the faculty of the Weizmann Institute of Science in 2017. Having received fellowships for academic excellence in 2008, 2009, and 2011, Dr. Avinoam received an EIPOD interdisciplinary postdoctoral fellowship in 2012. He is the recipient of prestigious grants including those from the Israel Science Foundation (ISF) and the European Research Council (ERC).